Esophageal Carcinoma
76
22
32
23
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Published Results
11 trials with published results (14%)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
2.6%
2 terminated out of 76 trials
92.0%
+5.5% vs benchmark
14%
11 trials in Phase 3/4
48%
11 of 23 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 23 completed trials
Clinical Trials (76)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
Yoga Program for Improving the Quality of Life in Couples Coping With Cancer
The Vanguard Study: Testing a New Way to Screen for Cancer
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Postoperative Hypoxemia Increases the Risk of Anastomotic Leak After Radical Esophagectomy
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
Impact of Prehabilitation in Oncology Via Exercise- Esophageal (IMPROVE-Esophageal)
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
The Impact of Surgical Treatment on Survival in Localized Small Cell Esophageal Cancer
18F-FSPG PET/CT as a Non-Invasive Imaging Biomarker for Treatment Response to Chemoradiation in Esophageal Cancer
National Cancer Institute "Cancer Moonshot Biobank"
Timing of Minimally Invasive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma
Effect of Feeding Jejunostomy on Sarcopenia in Patients With Esophageal Cancer
CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC
Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers
Inter-Observer Delineation Differences in Esophageal Cancer GTV on MR, CT, and PET/CT Protokol šečerov Ermenc 28dec19
PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung or Esophageal Cancer, EUCLID Trial